Lupin has launched Desoximetasone Topical Spray, in the US market. It is used for treatment of plaque psoriasis. In a regulatory filing the company stated,...
Lupin has received approval from the UK health regulator its Goa facility. In a regulatory filing the company stated that, it has received approval from UK MHRA...
Lupin has associated with Mylan to commercialize Enbrel biosimilar. Enbrel is a TNF-inhibitori suggested to treat certain autoimmune diseases, including rheumatoid arthritis, psoriatic arthritis, plaque psoriasis and...